financetom
Business
financetom
/
Business
/
Blackstone's All-Cash Proposed Offer for Hipgnosis Viewed Favorably by Board
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blackstone's All-Cash Proposed Offer for Hipgnosis Viewed Favorably by Board
Apr 22, 2024 4:18 AM

06:57 AM EDT, 04/22/2024 (MT Newswires) -- Hipgnosis Songs Fund said on Monday that it is reviewing a proposed offer for the company by Blackstone (BX) that "is at a value that it would be minded to recommend to its shareholders should Blackstone announce a firm intention to make an offer".

Blackstone (BX) said on Saturday that it had made a new proposal to acquire the issued and to be issued share capital of Hipgnosis at a price of $1.24 per share in cash, according to a regulatory filing. It is the private equity investor's fourth proposal.

It comes hot on the heels of an offer from Concord Chorus, an entity indirectly controlled by Alchemy Copyrights, LLC, last Thursday to acquire the company for at least $1.16 per share in cash.

If Blackstone's proposal becomes a firm offer, it would value the music repository, which includes rights to songs by Shakira and Red Hot Chili Peppers, at about $1.5 billion, according to reports by several news outlets.

"Blackstone strongly encourages the board of Hipgnosis to recognise the significant increase in value available to all shareholders" under its proposal, the company said in a statement dated Saturday.

The private equity company also said that under the terms of an investment advisory agreement in 2018 between its portfolio company Hipgnosis Song Management Limited, as investment adviser, and Hipgnosis, Hipgnosis Song Management Limited has "has an option" to purchase the entire portfolio of songs from Hipgnosis if the agreement is terminated.

It said that the option could be exercisable "at any point in time during the six month period following the effective date of termination of the IAA [investment advisory agreement]".

"Blackstone and its portfolio company HSM [Hipgnosis Song Management Limited], having taken extensive legal advice, remain confident in the enforceability of the option," it added.

Hipgnosis Songs Fund Limited said in its statement on Monday that there could be no certainty that a firm offer would be made for the company by Blackstone, nor as to the terms of any such offer.

It said that the Hipgnosis directors continue to recommend to Hipgnosis shareholders the cash offer by Concord Chorus Limited.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ebay Insider Sold Shares Worth $6,694,014, According to a Recent SEC Filing
Ebay Insider Sold Shares Worth $6,694,014, According to a Recent SEC Filing
May 26, 2025
04:41 PM EDT, 05/23/2025 (MT Newswires) -- Julie A Loeger, Senior Vice President, Chief Growth Officer, on May 21, 2025, sold 92,895 shares in Ebay ( EBAY ) for $6,694,014. Following the Form 4 filing with the SEC, Loeger has control over a total of 123,282 common shares of the company, with 123,282 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1065088/000112760225015493/xslF345X05/form4.xml ...
Mirion Technologies Insider Sold Shares Worth $8,972,350, According to a Recent SEC Filing
Mirion Technologies Insider Sold Shares Worth $8,972,350, According to a Recent SEC Filing
May 26, 2025
04:42 PM EDT, 05/23/2025 (MT Newswires) -- Lawrence D Kingsley, Director, on May 21, 2025, sold 500,000 shares in Mirion Technologies ( MIR ) for $8,972,350. Following the Form 4 filing with the SEC, Kingsley has control over a total of 4,261,287 Class A common shares of the company, with 61,287 shares held directly and 4,200,000 controlled indirectly. SEC Filing:...
Prothena to Stop Birtamimab Development After Trial for AL Amyloidosis Fails to Meet Primary Endpoint
Prothena to Stop Birtamimab Development After Trial for AL Amyloidosis Fails to Meet Primary Endpoint
May 26, 2025
04:42 PM EDT, 05/23/2025 (MT Newswires) -- Prothena ( PRTA ) said late Friday that it will discontinue the development of birtamimab after the phase 3 Affirm-Al trial of monoclonal antibody failed to meet the primary endpoint in treating patients with AL amyloidosis, or amyloid light chain amyloidosis. The company said it will also stop the open-label extension of the...
Merchants Bancorp Files $500 Million Mixed Shelf
Merchants Bancorp Files $500 Million Mixed Shelf
May 26, 2025
04:42 PM EDT, 05/23/2025 (MT Newswires) -- Merchants Bancorp ( MBIN ) filed a mixed shelf registration to raise up to $500 million through the sale of any combination of its securities from time to time, according to a Friday filing. The filing covers debt securities, common stock, preferred stock, depositary shares, purchase contracts, warrants, and units. Merchants said the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved